Kilitch Drugs (India) Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting

Kilitch Drugs' Board approved consolidated results for the quarter & half-year ended Sept 30. H1 revenue grew to Rs. 92.06 Cr with PAT at Rs. 11.22 Cr. Also, the company successfully completed a Rs. 49.93 Cr rights issue to fund its Greenfield project.